Association of COX-2 promoter polymorphism with gastrointestinal tract cancer in Iran

Biochemical Genetics

Volumn 48, Issue 11-12, 2010, Pages 915-923

  Biramijamal, Firouzeh ^a   Basatvat, Shaghayegh ^a   Hossein Nezhad, Arash ^b   Soltani, Maryam Sadat ^a   Akbari Noghabi, Kambiz ^a   Irvanloo, Guity ^c   Shamimi, Kourosh ^c  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IRAN; MALE; PROMOTER REGION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE FREQUENCY; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 78649316790     PISSN: 00062928     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10528-010-9372-x     Document Type: Article

References (42)

1. BR Achyut UC Ghoshal N Moorchung B Mittal 2009 Role of cyclooyegenase-2 functional gene polymorphisms in Helicobacter pylori gastritis and gastric atrophy Mol Cell Biochem 321 1-2 103 109 1:CAS:528:DC%2BD1MXktVWqtQ%3D%3D 10.1007/s11010-008-9924-0 18825488
2. HB Ben Nasr K Chahed N Bouaouina L Chouchane 2009 PTGS2 (COX-2) -765 G>C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma Mol Biol Rep 36 1 193 200 1:CAS:528:DC%2BD1cXhtl2mu7rL 10.1007/s11033-007-9166-3 17968676
3. MM Bertagnoli CJ Eagle AG Zauber M Redston A Breazna K Kim J Tang RB Rosenstein A Umar D Bagheri NT Collins J Burn DC Chung T Dewar TR Foley N Hoffman F Macrae RE Pruitt JR Saltzman B Salzberg T Sylwestrowicz ET Hawk 2009 Five-year efficacy and safety analysis of the Adenoma prevention with Celecoxib Trial Cancer Prev Res 2 4 310 321 10.1158/1940-6207.CAPR-08-0206
4. F Biramijamal AA Allameh P Mirbod H-J Groene M Hollstein 2001 Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinoma from Northern Iran Cancer Res 61 3119 3123 1:CAS:528: DC%2BD3MXivFGqsb4%3D 11306496
5. DG Cox C Pontes E Guino M Navarro A Osorio F Canzian V Moreno 2004 Polymorphism in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer Br J Cancer 91 2 339 343 1:CAS:528:DC%2BD2cXls1ehsbg%3D 15173859 (Pubitemid 39037081)
6. MS Fazeli MG Ghavami Adel AH Lebaschi 2007 Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage and differentiation in Iran from 1995 to 2001 as observed in Tehran university Dis Colon Rectum 50 7 990 995 10.1007/s10350-007-0248-z 17525859
7. IP Felin I Grivicich CR Felin A Regner AB da Rocha 2008 p53, p16 E COX-2 expression in esophageal squamous cell carcinoma and histopathological association Arq Gastroenterol 45 4 308 312 10.1590/S0004-28032008000400009 19148359
8. R Fux M Schwab KP Thon CH Gleiter P Fritz 2005 Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival Clin Cancer Res 11 13 4754 4760 1:CAS:528:DC%2BD2MXlvVGhur8%3D 10.1158/1078-0432.CCR-04-2586 16000571 (Pubitemid 41557195)
9. A Greenhough HJM Smart AE Moore HR Roberts AC Williams C Paraskeva A Kaidi 2009 The cox-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis 30 3 377 386 1:CAS:528:DC%2BD1MXivFSiuro%3D 10.1093/carcin/bgp014 19136477
10. RE Harris J Beebe-Donak GA Alshafie 2008 Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors BMC Cancer 8 237 10.1186/1471-2407-8-237 18702823
11. HM Hu CH Kuo CH Lee IC Wu KW Lee JM Lee YG Goan SH Chou EL Kao MT Wu DC Wu 2009 Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seroposivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study BMC Gastroenterol 9 37 10.1186/1471-230X-9-37 19463183
12. L Ke 2002 Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90 Int J Cancer 102 3 271 274 1:CAS:528:DC%2BD38XotlaitLY%3D 10.1002/ijc.10706 12397650 (Pubitemid 35222298)
13. PC Konturek J Kania G Burnat EG Hahn SJ Konturek 2005 Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract J Physiol Pharmacol 56 Suppl 5 57 73 16247189
14. JO Kristinsson P van Westerveld RHM te Morsche HMJ Roelofs T Wobbs BJM Witterman ACITL Tan MGH van Oijen JBMJ Janson WHM Peters 2009 Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma World J Gastroenterol 15 28 3493 3497 1:CAS:528:DC%2BD1MXpsF2ru7Y%3D 10.3748/wjg.15.3493 19630103
15. X Liu P Li ST Zhang H You JD Jia ZL Yu 2008 COX-2 mRNA expression in esophageal aquamous cell carcinoma (ESCC) and effect by NSAID Dis Esophagus 21 1 9 14 1:CAS:528:DC%2BD1MXmvFKisw%3D%3D 18197933
16. E Mahboubi J Kmet PJ Cook NE Day P Ghadirian S Salmasizadeh 1973 Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry Br J Cancer 28 3 197 214 1:STN:280:DyaE2c%2Fgslyjug%3D%3D 4743904
17. M Mahdavinia F Bishesari R Ansari N Norouzbeigi A Khaleghinejad M Hormazdi N Rakhshani R Malekzadeh 2005 Family history of colorectal cancer in Iran BMC Cancer 5 112 10.1186/1471-2407-5-112 16143045 (Pubitemid 41461023)
18. M Mahdavinia F Bishesari F Verginelli A Cumashi R Lattanzio M Sotoudeh R Ansari D Semeraro M Hormazdi H Fakheri N Rakhshani L De Lellis MC Curia A Cama M Piantelli R Malekzadeh S Iacobelli R Mariani-Costantini 2008 P53 mutations in colorectal cancer from northern Iran: relationship with site of tumor origin, microsatellite instability and K-ras mutations J Cell Physiol 216 2 543 550 1:CAS:528:DC%2BD1cXotFyrtbo%3D 10.1002/jcp.21428 18330889 (Pubitemid 351898483)
19. R Malekzadeh F Bishesari M Mahdavinia R Ansari 2009 Epidemiology and molecular genetics of colorectal cancer in Iran: a review Arch Iran Med 12 2 161 169 1:CAS:528:DC%2BD1MXhtVyhurzJ 19249887
20. R Miao N Lui Y Wang L Li X Yu J Jiang Li 2008 Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior Hepatogastroenterology 55 88 2012 2015 19260469
21. RM Navaratnam J Chowaniec MC Winslet 1999 The molecular biology of colorectal cancer development and associated genetic events Ann R Coll Surg Engl 81 5 312 319 1:STN:280:DC%2BD3c7gvFOlug%3D%3D 10645173
22. RC Panguluri LO Long W Chen S Wang A Coulibaly F Ukoli A Jackson S Weinrich C Ahaghotu W Issacs RA Kittles 2004 Cox-2 gene promoter haplotypes and prostate cancer risk Carcinogenesis 25 6 961 966 1:CAS:528:DC%2BD2cXksVahtLs%3D 10.1093/carcin/bgh100 14754878 (Pubitemid 38886082)
23. JM Park JE Choi MH Chae WK Lee SI Cha J Son CH Kim S Kam YM Kang TH Jung JY Park 2006 Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study BMC Cancer 6 70 10.1186/1471-2407-6- 70 16542464 (Pubitemid 43786478)
24. C Pereira H Sousa P Ferreria M Fragoso L Moreira-Dias C Lopes R Medeiros M Dinis-Ribeiro 2006 765G>C COX-2 polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia World J Gastroenterol 12 34 5473 5478 1:CAS:528:DC%2BD28XhtFehtrfP 17006983
25. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, Jafari E, Rakhshani N, Salahi R, Semnani S, Kamangar F, Abnet CC, Ponder B, Day N, Dawsey S M, Boffetta P, Malekzadeh R (2010) Cohort profile: The Golestan Cohort study, a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 39(1):52-59
26. S Sadeghi CJ Bain N Pandeya PN Webb AC Green DC Whiteman 2008 Aspirin, nonsteroidal anti-inflammatory drugs and the risk of cancers of the esophagus Cancer Epidemiol Biomarkers Prev 17 5 1169 1178 1:CAS:528:DC%2BD1cXmtVClsbo%3D 10.1158/1055-9965.EPI-07-2852 18483339
27. P Samareh Pahlavan R Kanthan 2006 The epidemiology and clinical findings of colorectal cancer in Iran J Gastrointestin Liver Dis 15 1 15 19
28. M Sanak W Szczeklik A Szczeklik 2005 Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma J Allergy Clin Immunol 116 1 221 223 1:CAS:528:DC%2BD2MXlvVWns7c%3D 10.1016/j.jaci.2005.03.010 15990799 (Pubitemid 40909772)
29. A Sepehr P Taniere G Martel-Planche AA Zia'ee F Rastgar-Jazii M Yazdanbod G Etemad-Moghadam F Kamangar F Saidi P Hainaut 2001 Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran Oncogene 20 50 7368 7374 1:CAS:528:DC%2BD3MXovVOntLY%3D 10.1038/sj.onc.1204912 11704866 (Pubitemid 33078207)
30. A Shamma H Yamamoto Y Doki J Okami M Kondo Y Fujiwara M Yano M Inoue N Matsuura H Shiozaki M Monden 2000 Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus Clin Cancer Res 6 4 1229 1238 1:CAS:528:DC%2BD3cXjtVOqsbc%3D 10778945
31. C Siemes LE Visser JW Coebergh A Hofman AU Uitterlinden BH Stricker 2008 Protective effect of NSAIDs on cancer and influence of COX-2 (G-765C) genotype Curr Cancer Drug Targets 8 8 753 764 1:CAS:528:DC%2BD1cXhsVKhsrrO 10.2174/156800908786733414 19075598
32. PM Stewart SM Prescott 2009 Can Licorice colon cancer? J Clin Invest 119 4 76 85 10.1172/JCI38936
33. W Tan J Wu X Zhang Y Guo J Liu T Sun B Zhang D Zhao M Yang D Yu D Lin 2007 Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer Carcinogenesis 28 6 1197 1201 1:CAS:528:DC%2BD2sXnt1Cmt7s%3D 10.1093/carcin/bgl242 17151091 (Pubitemid 47064309)
34. JB Tuynman L Vermeulen EM Boon K Kemper AH Zwinderman MP Peppelenbosch DJ Richel 2008 Cyclooxygenase-2 inhibition inhibits c-Met kinase activity and Wnt activity in colon cancer Cancer Res 68 4 1213 1220 1:CAS:528: DC%2BD1cXhvFemurY%3D 10.1158/0008-5472.CAN-07-5172 18281498 (Pubitemid 351272241)
35. CM Ulrich J Whitton Yu J-Ho J Sibert R Sparks JD Potter J Bigler 2005 PTGS2 (COX-2) -765G>C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs Cancer Epidemiol Biomarkers Prev 14 3 616 619 1:CAS:528:DC%2BD2MXit1Kgtb0%3D 10.1158/1055-9965. EPI-04-0510 15767339 (Pubitemid 40489204)
36. R Upadhyay M Jain S Kumar UC Ghoshal B Mittal 2009 Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma Mutat Res 663 1-2 52 59 1:CAS:528:DC%2BD1MXktlymu7k%3D 19428370
37. ZX Wang Hb Bian JS Yang W De XH Ji 2009 Adeno virus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer Cancer Biol Ther 8 15 1480 1488 1:CAS:528:DC%2BC3cXjt1aisLg%3D 19571664
38. AW Wu J Gu JF Ji ZF Li GW Xu 2003 Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis World J Gastroenterol 9 9 1990 1994 1:CAS:528: DC%2BD3sXot1Ggu78%3D 12970891
39. LL Xing ZN Wang L Jiang Y Zhang YY Xu J Li Y Luo X Zhang 2008 Cyclooxygenase 2 polymorphism and colorectal cancer: -765 G>C variant modifies risk associated with smoking and body mass index World J Gastroenterol 14 11 1785 1789 1:CAS:528:DC%2BD1cXlsVeksrY%3D 10.3748/wjg.14.1785 18350611 (Pubitemid 351493386)
40. X Zhang X Miao W Tan B Ning Z Liu Y Hong W Song Y Guo X Zhang Y Shen B Qiang FF Kadlubar D Lin 2005 Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer Gastroenterology 129 2 565 576 1:CAS:528:DC%2BD2MXpvVWmsbw%3D 16083713
41. MZ Zhang J Xu B Yao H Yin Q Cai MJ Shrubsole X Chen V Kon W Zheng A Pozzi RC Harris 2009 Inhibition of 11 beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor Cox-2 pathway and suppresses colon carcinogenesis in mice and humans J Clin Invest 119 4 876 885 1:CAS:528:DC%2BD1MXktlSnt78%3D 10.1172/JCI37398 19307727
42. D Zhao D Xu X Zhang L Wang W Tan Y Guo D Yu H Li P Zhao D Lin 2009 Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin Gastroenterology 136 5 1659 1668 1:CAS:528:DC%2BD1MXmtFWqu7s%3D 10.1053/j.gastro.2009.01.071 19422084